ReviewCurrent oncology reports2024

Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review.

Simran Kalsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.